Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,536,009
-
Share change
-
-981,947
-
Total reported value
-
$132,209,858
-
Price per share
-
$8.51
-
Number of holders
-
52
-
Value change
-
-$16,950,084
-
Number of buys
-
26
-
Number of sells
-
25
Institutional Holders of Kiniksa Pharmaceuticals Intern - COM (KNSA) as of Q3 2019
As of 30 Sep 2019 Kiniksa Pharmaceuticals Intern - COM (KNSA) had 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,536,009 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, HILLHOUSE CAPITAL ADVISORS, LTD., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, BlackRock Inc., Sofinnova Investments, Inc., AMERIPRISE FINANCIAL INC, VHCP Management II, LLC, and CITADEL ADVISORS LLC.
This table shows 52 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.